Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice
Suzan Dziennis, Sarah Mader, Kozaburo Akiyoshi, Xuefang Ren, Patricia Ayala, Gregory G. Burrows, Arthur A. Vandenbark, Paco S. Herson, Patricia D. Hurn, Halina A. Offner
Dive into the research topics of 'Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice'. Together they form a unique fingerprint.